English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Takeda ends partnership with Denali Therapeutics on dementia drug program
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Citeline reports first decline in pharma R&D pipeline since the 1990s
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Experts discuss strategies to reduce risk in drug development at API webinar
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

JMIR Publications releases article on advances in precision oncology
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Study shows how blind people map surroundings using sound
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Harvard Medical School researchers study exposome's impact on disease risk
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Mayo Clinic researchers develop method to identify proteins triggering immune responses
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Bliksem Health founder Rojas on 340B program: 'The safety net became the fishing net'

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes